Biggest News Aggregation in the World
📰 Michael Erman News

Page 80 - Michael Erman News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Michael Erman. Real-time updates on events, politics, business and more.

Analysis: Tougher terms: why the EU is paying more for new COVID shots

By Syndicated Content By Francesco Guarascio BRUSSELS (Reuters) – The European Union has agreed to pay a premium on new orders of COVID-19 vaccines because it is requiring tougher terms to be met, European officials said, as the bloc tries to protect supplies after a rocky start to its vaccination campaign. The higher price is less than the United States has agreed to pay in its latest order in July. On Sunday, the Financial Times reported the EU has agreed to pay Pfizer and BioNT...
United States France General New Jersey Bruxelles Capitale Francesco Guarascio Josephine Mason
Source: whbl.com

Is This the WTO Waiver End Game? | McDonnell Boehnen Hulbert & Berghoff LLP

Pfizer and BioNTech Agree to Vaccine Technology Transfer with South Africas Biovac Institute As reported by Reuters* on Wednesday ( e"), Pfizer and BioNTech, manufacturers and developers of an mRNA-based vaccine against SARS-CoV-2, have agreed to help the South African drug maker Biovac Institute produce about 100 million doses per year of its vaccine, specifically to be targeted to African nations. As described by the Reuters article, Biovac Institute is "a joint venture between the South Afri...
South Africa South African Richard Pullin Mark Potter Andrei Iancu Morena Makhoana

U.S. buys 200M more doses of Pfizer/BioNTech COVID-19 vaccine

U.S. buys 200M more doses of Pfizer/BioNTech COVID-19 vaccine The deal comes as the Delta variant of the coronavirus sweeps across the country and drives up infections, contributing to the debate over whether or not Americans will need a booster dose this fall. Written By: Manas Mishra and Michael Erman / Reuters | 2:44 pm, Jul. 23, 2021 × A medical worker prepares a dose of the Pfizer-BioNTech "Comirnaty" vaccine against the coronavirus disease (COVID-19) in a vaccinatio...
United States New Jersey Manas Mishra Dan Grebler Albert Bourla Sriraj Kalluvila

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Catalent plans $100 mln expansion at vaccine plant in Italy

Article content “We thought that this was the right place to create this capability, a capability that can be used for a public health emergency like COVID-19.” The company plans to install two 2,000-liter single-use bioreactors at the Agnani plant, as well as the infrastructure required for another six 2,000-liter single-use bioreactors. Catalent acquired the Agnani plant from Bristol Myers Squibb in January 2020 and quickly signed deals to fill and finish the AstraZeneca and J&J vaccines ...
Richard Pullin Bristol Myers Squibb Michael Erman பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் மைக்கேல் அர்மந்

U.S. to announce new warning on J&J coronavirus vaccine for autoimmune disorder -Washington Post

Article content J&J and the FDA were not immediately available for comment. GBS is a rare neurological condition in which the body’s immune system attacks the protective coating on nerve fibers. Most cases follow a bacterial or viral infection. The condition has been linked in the past to vaccinations – most notably to a vaccination campaign during a swine flu outbreak in the United States in 1976, and decades later to the vaccine used during the 2009 H1N1 flu pandemic. Last week, European ...
United States New Jersey Chris Reese Peter Graff Lisa Lambert Moderna Inc

Pfizer to ask FDA to authorize booster dose of COVID vaccine as Delta variant spreads

Article content Pfizer Chief Scientific Officer Mikael Dolsten said the recently reported dip in the vaccine’s effectiveness in Israel was mostly due to infections in people who had been vaccinated in January or February. The country’s health ministry said vaccine effectiveness in preventing both infection and symptomatic disease fell to 64% in June. We apologize, but this video has failed to load. Try refreshing your browser, or Pfizer to ask FDA to authorize booster dose of COVID vaccine...
United States United Kingdom Mikael Dolsten Dan Grebler William Schaffner Julie Steenhuysen

Pfizer va demander à la FDA d'autoriser un rappel supplémentaire de son vaccin pour lutter contre le variant Delta

&nbsp"; $(function(){ $.each($(".autopromo"),function(index,elmnt){ $(elmnt).css("display",""); $(elmnt).html(sHTMLAutopromo); }); if(window.screen.width Pfizer va demander à la FDA dautoriser un rappel supplémentaire de son vaccin pour lutter contre le variant Delta 09/07/2021 | 01:16 1 Message personnel : par Michael Erman et Julie Steenhuysen NEW YORK, 9 juillet (Reuters) - Pfizer prévoit de demander à la Food and Drug Admi...
United States Julie Steenhuysen Ministry Of Health Israel Michael Erman Julie Steenhuysen New York January Or February

Pfizer to seek U.S. authorization for COVID booster shot as Delta variant spreads

Publishing date: Jul 08, 2021  •  11 hours ago  •  4 minute read  •  A vial and syringe are seen in front of a displayed Pfizer and Biontech logo in this illustration taken Jan. 11, 2021. The vaccine presents a "significant oppotunity" to make profits after the pandemic is over, executive says. Photo by Dado Ruvic / Reuters Article content NEW YORK — Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmake...
United States United Kingdom Leslie Adler Mikael Dolsten Dan Grebler William Schaffner

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science